<VariationArchive RecordType="classified" VariationID="190301" VariationName="NC_000023.10:g.(20185970_20187287)_(20191368_20193188)del" VariationType="Deletion" Accession="VCV000190301" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-11-13" DateCreated="2015-05-22" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="188130" VariationID="190301">
      <GeneList>
        <Gene Symbol="RPS6KA3" FullName="ribosomal protein S6 kinase A3" GeneID="6197" HGNC_ID="HGNC:10432" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20149911" stop="20267097" display_start="20149911" display_stop="20267097" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20168028" stop="20284749" display_start="20168028" display_stop="20284749" Strand="-" />
          </Location>
          <OMIM>300075</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(20185970_20187287)_(20191368_20193188)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" outerStart="20185970" innerStart="20187287" innerStop="20191368" outerStop="20193188" display_start="20185970" display_stop="20193188" variantLength="7219" />
      </Location>
      <OtherNameList>
        <Name>7.2-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(20185970_20187287)_(20191368_20193188)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(20185970_20187287)_(20191368_20193188)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300075.0022" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(20185970_20187287)_(20191368_20193188)del AND Coffin-Lowry syndrome" Accession="RCV000170489" Version="6">
        <ClassifiedConditionList TraitSetID="3180">
          <ClassifiedCondition DB="MedGen" ID="C0265252">Coffin-Lowry syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-05-22" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25044551</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">5581017</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3180" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="823" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Coffin-Lowry syndrome</ElementValue>
                <XRef ID="Coffin-Lowry+Syndrome/1709" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010561" DB="MONDO" />
                <XRef ID="15182000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">COFFIN-LOWRY SYNDROME, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="300075.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation with osteocartilaginous abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coffin syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLS</ElementValue>
                <XRef Type="MIM" ID="303600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of affected individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild-to-moderate range and may also have the typical facial, hand, and skeletal findings noted in males.</Attribute>
                <XRef ID="NBK1346" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="192" DB="Orphanet" />
              <XRef ID="C0265252" DB="MedGen" />
              <XRef ID="MONDO:0010561" DB="MONDO" />
              <XRef Type="MIM" ID="303600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="405589" SubmissionDate="2021-08-20" DateLastUpdated="2022-10-01" DateCreated="2015-05-19">
        <ClinVarSubmissionID localKey="300075.0022_COFFIN-LOWRY SYNDROME" title="RPS6KA3, 7.2-KB DEL_COFFIN-LOWRY SYNDROME" />
        <ClinVarAccession Accession="SCV000222921" DateUpdated="2022-10-01" DateCreated="2015-05-19" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In cells derived from an affected member of the original family with Coffin-Lowry syndrome (CLS; 303600) reported by Lowry et al. (1971), Nishimoto et al. (2014) identified an in-frame deletion of exons 15 and 16 (r.1228_1443del216) in the RPS6KA3 gene, resulting in the deletion of 72 amino acids from 410 to 418 in the C-terminal kinase domain, predicting the loss of function of this domain. Microarray analysis indicated that the maximum size of the deletion was about 7.2 kb.</Attribute>
              <Citation>
                <ID Source="PubMed">5581017</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25044551</ID>
              </Citation>
              <XRef DB="OMIM" ID="303600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS6KA3" />
          </GeneList>
          <Name>RPS6KA3, 7.2-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">7.2-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300075.0022" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COFFIN-LOWRY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="405589" TraitType="Disease" MappingType="Name" MappingValue="COFFIN-LOWRY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265252" Name="Coffin-Lowry syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

